📈 Stocks
Investors Favor Eli Lilly Over Novo Nordisk After Downbeat Diagnosis
(4 days ago)
Investor sentiment turns bearish on Novo Nordisk while Eli Lilly gains favor amid shifting dynamics in the obesity-drug market.